Our research aimed to investigate whether soluble thrombomodulin (sTM) relieved Diquat (DQ)-induced acute kidney injury (AKI) via HMGB1/IκBα/NF-κB signaling pathways. An AKI rat model was constructed using DQ. Pathological changes in renal tissue were detected by HE and Masson staining. Gene expression was determined using qRT-PCR, IHC, and western blotting. Cell activity and apoptosis were analysed using CCK-8 and Flow cytometry, respectively. An abnormal kidney structure was observed in DQ rats. The levels of blood urea nitrogen (BUN), creatinine (CRE), uric acid (UA), oxidative stress, and inflammatory responses in the DQ group increased on the 7th day but decreased on the 14th day, compared with the control group. Additionally, HMGB1, sTM, and NF-kappaB (NF-κB) expression had increased in the DQ group compared with the control group, while the IκKα and IκB-α levels had decreased. In addition, sTM relieved the damaging effects of diquat on renal tubular epithelial cell viability, apoptosis, and the inflammatory response. The levels of HMGB1, TM, and NF-κB mRNA and protein were significantly decreased in the DQ + sTM group compared with the DQ group. These findings indicated that sTM could relieve Diquat-induced AKI through HMGB1/IκBα/NF-κB signaling pathways, which provides a treatment strategy for Diquat-induced AKI.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fct.2023.113871DOI Listing

Publication Analysis

Top Keywords

soluble thrombomodulin
8
acute kidney
8
kidney injury
8
stm relieved
8
aki hmgb1/iκbα/nf-κb
8
hmgb1/iκbα/nf-κb signaling
8
signaling pathways
8
compared control
8
control group
8
group compared
8

Similar Publications

Background: Acute respiratory failure (ARF) is common in critically ill patients, and 50% of patients in intensive care units require mechanical ventilation [3, 4]. The COVID-19 pandemic revealed that COVID-19 infection induced ARF caused by damage to the microvascular pulmonary endothelium. In a randomized clinical trial, mechanically ventilated COVID-19 patients with severe endotheliopathy, as defined by soluble thrombomodulin (sTM) ≥ 4 ng/mL, were randomized to evaluate the effect of a 72-h infusion of low-dose prostacyclin 1 ng/kg/min or placebo.

View Article and Find Full Text PDF

Thrombomodulin (TM) is an important regulator of intravascular blood coagulation and inflammation. TM inhibits the procoagulant and proinflammatory activities of thrombin and promotes the thrombin-induced activation of protein C (PC) bound to the endothelial PC receptor (EPCR). Activated PC (APC) inactivates coagulation factors Va and VIIIa, thereby inhibiting blood clotting.

View Article and Find Full Text PDF

Markers of Endothelial Injury in Extracorporeal Membrane Oxygenation: A New Risk Assessment Method.

J Surg Res

December 2024

Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, District of Columbia; Department of Biochemistry and Molecular & Cellular Biology, Georgetown University School of Medicine, Washington, District of Columbia; Department of Surgery, Georgetown University School of Medicine, Washington, District of Columbia; The Burn Center, Department of Surgery, MedStar Washington Hospital Center, Washington, District of Columbia; Department of Plastic and Reconstructive Surgery, Georgetown University School of Medicine, Washington, District of Columbia. Electronic address:

Article Synopsis
  • ECMO usage is increasing, but determining which patients will benefit the most is challenging, making risk stratification crucial.
  • This study evaluated the impact of two biomarkers, SDC-1 and soluble thrombomodulin (sTM), on mortality rates in patients on venoarterial ECMO.
  • Results showed that higher levels of sTM significantly correlate with increased mortality risk, while SDC-1 levels are marginally predictive; these findings suggest that incorporating these biomarkers could enhance existing scoring systems for better patient assessment.
View Article and Find Full Text PDF
Article Synopsis
  • * It presents a case study of a woman in her 70s who experienced sudden weakness on one side of her body, ultimately diagnosed with a type of stroke linked to her APL.
  • * Despite treatment efforts including recombinant human soluble thrombomodulin and all-trans retinoic acid, her condition worsened due to complications from APL, leading to her death; highlighting the importance of assessing arterial health before initiating treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Individuals with type 2 diabetes and increased albuminuria face a higher risk of cardiovascular disease and premature death, highlighting the need for improved understanding of their health risks.
  • A cross-sectional study involving 463 individuals analyzed the relationship between albuminuria and various markers related to blood vessel function, clotting, and platelet activity, revealing important findings.
  • Results showed a clear link between higher albuminuria levels and increased markers of endothelial function and fibrinogen, but no connection was found between albuminuria and thrombin generation or platelet activity among the participants without cardiovascular disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!